Critical Care Medicine-Hematologic and Oncologic Disorders>>>>>Hemopoietic Cell Transplantation
Question 1#

A 34-year-old woman presents to the ED with several days of worsening abdominal pain, anorexia, nausea, and copious diarrhea. Three months ago, she had underwent matched unrelated-donor allogeneic stem cell transplant for acute lymphocytic leukemia (ALL). Examination reveals an:

She is given 30 mL/kg IVF and SBP remains in the 80s, prompting ICU admission. Laboratory test results are notable for:

Which of the following statements about the most likely diagnosis is true?

A. Liver biopsy should be a high priority
B. The extent of skin and gut involvement predicts a higher mortality
C. Initial treatment in this case would be topical steroids
D. The pathology is primarily neutrophil-driven
E. Aggressive treatment will reduce the probability of relapsed ALL

Correct Answer is B


Correct Answer: B

The most likely diagnosis here is acute graft-versus-host disease (GVHD), a multisystem inflammatory attack on the host’s tissues by the grafted immune system. Risk factors include the degree of HLA mismatch and the prophylactic regimen employed posttransplant. The pathogenesis involves T lymphocytes primarily, though neutrophils and activated macrophages contribute to a lesser extent. The most common sites of acute GVHD are the GI tract, skin, and liver, and presentation typically occurs within the first few months of transplant. A grading system exists based on the extent of skin involvement, severity of diarrhea, and bilirubin elevations, with higher grades associated with reduced survival. Diagnosis may be made on clinical grounds along with the classic rash of GVHD (maculopapular, involving palms/soles), though biopsy of skin or the distal GI tract (typically not liver) may be performed in cases where infection is higher in the differential diagnosis. Although topical steroids may be effective in GVHD limited to the skin, for any signs of systemic involvement systemic glucocorticoids are indicated as first line treatment. Notably, intense immunosuppression over a prolonged period exposes the host to many risks, including a reduction in the graft-versus-malignancy effect that helps allogeneic stem cell recipients maintain long-term remissions. 


  1. Kuba A, Raida L. Graft versus host disease: from basic pathogenic principles to DNA damage response and cellular senescence. Mediators Inflamm. 2018;2018:9451950.
  2. Cahn J-Y, Klein JP, Lee SJ, et al. Prospective evaluation of 2 acute graftversus-host (GVHD) grading systems: a joint Société Française de Greffe de Moëlle et Thérapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study. Blood. 2005;106:1495-1500.
  3. Firoz BF, Lee SJ, Nghiem P, Qureshi AA. Role of skin biopsy to confirm suspected acute graft-vs-host disease: results of decision analysis. Arch Dermatol. 2006;142:175-182.
  4. Ross WA, Ghosh S, Dekovich AA, et al. Endoscopic biopsy diagnosis of acute gastrointestinal graft-versus-host disease: rectosigmoid biopsies are more sensitive than upper gastrointestinal biopsies. Am J Gastroenterol. 2008;103:982-989.
  5. Rashidi A, DiPersio JF, Sandmaier BM, Colditz GA, Weisdorf DJ. Steroids versus steroids plus additional agent in frontline treatment of acute graft-versus-host disease: a systematic review and meta-analysis of randomized trials. Biol Blood Marrow Transplant. 2016;22:1133-1137.